Lasa Supergenerics Limited

NSE LASA.NS

Lasa Supergenerics Limited Price to Sales Ratio (P/S) on February 07, 2025: 1.17

Lasa Supergenerics Limited Price to Sales Ratio (P/S) is 1.17 on February 07, 2025, a -9.22% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Lasa Supergenerics Limited 52-week high Price to Sales Ratio (P/S) is 1.54 on September 05, 2024, which is 31.69% above the current Price to Sales Ratio (P/S).
Lasa Supergenerics Limited 52-week low Price to Sales Ratio (P/S) is 0.82 on March 26, 2024, which is -29.42% below the current Price to Sales Ratio (P/S).
Lasa Supergenerics Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 1.20.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: LASA.NS

Lasa Supergenerics Limited

CEO	Dr. Omkar Pravin Herlekar
IPO Date	Sept. 21, 2017
Location	India
Headquarters	No. 506 & 507, Midas Sahar Plaza
Employees	77
Sector	Consumers Staples
Industries Pet Food Agriculture Biotechnology Cleaning Supplies Cosmetics Dairy & Milk Personal Care Pharmaceuticals

Description

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.

Key trends

Past 5 years